Description:
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within minutes, typically using lateral flow technology or dip stick methods. Meanwhile, the global home IVD testing market is burgeoning with potential. The home collection IVD testing market includes kits obtained from pharmacies or online, where patients collect specimens, send them to a lab for testing, and receive results back.
Key Features:
- Detailed market estimates by specialty, covering various segments such as cholesterol, drugs of abuse, fecal occult blood, glucose/HbA1c, infectious disease, COVID-19/flu/RSV, HIV, pregnancy and fertility, rapid coagulation, and genetic testing (excluding ancestry genetic testing)
- Market segmentation by venue: at-home test (patient gets result at home) and home collection test (sent to lab for results later)
- Analysis of trends and market dynamics driving the growth of at-home and home collection testing
- Forecasted market analysis for 2022-2027 based on demographic trends, technological advancements, and global expansion
- Insight into the evolution of consumer behavior toward healthcare and the rise of medical consumers seeking greater control over their health
Market Trends:
The report highlights the shift in consumer behavior toward healthcare, driven by a desire for greater control and access to personal health information. This shift has led to the growth of the home IVD testing market, with consumers becoming more cost-conscious and seeking early disease detection, personalized medicine, and more control over their health decisions. The report also discusses the impact of genetic testing on consumer awareness and the passage of the Genetic Information Nondiscrimination Act (GINA), which has encouraged consumers to explore their genetic makeup without fear of discrimination.
Why Buy This Report:
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023 provides a comprehensive overview of the evolving landscape of at-home and home collection testing. With detailed market estimates, analysis of key trends, and forecasts for the future, this report is an essential resource for businesses and stakeholders in the healthcare industry looking to understand and navigate the growing home testing market.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global At-Home IVD Market, by Sample Type, 2022 ($BN)
| Sample Type | Market Value |
| Blood | $XX Million |
| Urine | $XX Million |
| Oral/Saliva | $XX Million |
| Nasal | $XX Million |
| Stool | $XX Million |
| Other | $XX Million |
| Total At-Home IVD Market | $XX Million |
Source: Kalorama Information
